Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment.
Zucker
S
S
Department of Research, Veterans Affairs Medical Center, Northport, New York 11768.
Lysik
R M
RM
Zarrabi
H M
HM
Moll
U
U
Tickle
S P
SP
Stetler-Stevenson
W
W
Baker
T S
TS
Docherty
A J
AJ
D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000097:blood*; D008991:Monitoring, Physiologic; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000097:blood; D009369:Neoplasms / Q000097:blood* / Q000473:pathology / Q000628:therapy; D011237:Predictive Value of Tests; D011247:Pregnancy; D011506:Proteins / Q000032:analysis*; D019716:Tissue Inhibitor of Metalloproteinase-2; D019714:Tissue Inhibitor of Metalloproteinases
D014408:Biomarkers, Tumor; D006023:Glycoproteins; D009363:Neoplasm Proteins; D011506:Proteins; D019714:Tissue Inhibitor of Metalloproteinases; D019716:Tissue Inhibitor of Metalloproteinase-2; D008666:Metalloendopeptidases